Andy Liu
Current Organizations / Institutes
The organizations/institutes from the scholar's latest article
Previous Organizations / Institutes
The organizations / institutes from the scholar's other articles in the past ten years
Research Subjects
Andy Liu has a total of 26 co-authors. Here are the top co-authors by number of shared publications:
Jeffrey D. Klausner
Department of Population and Public Health Sciences, Keck School of Medicine of the University of Southern California, Los Angeles, CA
2 shared publicationsLorenzo Giacani
Department of Medicine, University of Washington, Seattle
2 shared publicationsArlene C. Seña
Division of Infectious Diseases, Department of Medicine, University of North Carolina at Chapel Hill, Chapel Hill, NC
1 shared publicationCaroline E. Cameron
Department of Medicine, University of Washington, Seattle, WA, USA
1 shared publication- Chirag G. Patil
Cedars-Sinai Medical Center, Los Angeles, CA 90048, USA
1 shared publication - Elaine Huang
Department of Medicine, Keck School of Medicine, University of Southern California, Los Angeles, CA
1 shared publication
Latest Publications
- Open Access
- 23 July 2025
- Published by Oxford University Press (OUP) in The Journal of Infectious Diseases
- Vol. 232 (4) , 760-766
Syphilis Pathogenesis: Host Immune Response vs Pathogen Immune Evasion
Syphilis, caused by Treponema pallidum subspecies pallidum, remains a significant global health problem despite being preventable and curable. The pathogen's ability to evade the immune system by using virulence factor-based strategies and invading immune-privileged sites enables persistent infection in the untreated host. This translational update describes the host innate and adaptive immune responses in syphilis and the sophisticated mechanisms employed by T. pallidum to avoid immune clearance. Recent advances in immune profiling have enhanced our understanding of the host immune response and identified potential biomarkers for disease staging and treatment monitoring. However, knowledge gaps remain regarding T. pallidum's immune evasion mechanisms, the dynamics of cellular and humoral immunity, and the characteristics of long-term protective immune responses against T. pallidum. Bridging these gaps by integrating microbiology, immunology, and multiomics approaches is crucial for advancing diagnostic tools, therapeutic strategies, and vaccine development to ultimately reduce the global burden of syphilis.
- 23 July 2025
- Published by Oxford University Press (OUP) in The Journal of Infectious Diseases
- Vol. 232 (4) , 760-766
Open AccessSyphilis Pathogenesis: Host Immune Response vs Pathogen Immune Evasion
Syphilis, caused by Treponema pallidum subspecies pallidum, remains a significant global health problem despite being preventable and curable. The pathogen's ability to evade the immune system by using virulence factor-based strategies and invading immune-privileged sites enables persistent infection in the untreated host. This translational update describes the host innate and adaptive immune responses in syphilis and the sophisticated mechanisms employed by T. pallidum to avoid immune clearance. Recent advances in immune profiling have enhanced our understanding of the host immune response and identified potential biomarkers for disease staging and treatment monitoring. However, knowledge gaps remain regarding T. pallidum's immune evasion mechanisms, the dynamics of cellular and humoral immunity, and the characteristics of long-term protective immune responses against T. pallidum. Bridging these gaps by integrating microbiology, immunology, and multiomics approaches is crucial for advancing diagnostic tools, therapeutic strategies, and vaccine development to ultimately reduce the global burden of syphilis.
- Open Access
- 22 July 2024
- Published by Wolters Kluwer Health in Sexually Transmitted Diseases
- Vol. 51 (11) , e49-e53
New Pathways in Syphilis Vaccine Development
The New Pathways in Syphilis Vaccine Development meeting was held before the start of the STI & HIV 2023 World Congress as a pre-meeting symposium to highlight recent advances in the development of an effective syphilis vaccine and discuss the challenges still faced by investigators. Internationally renowned public health officials, clinical investigators, and basic researchers from academia, government, and community-based organizations met on July 24, 2023, in Chicago, Illinois. Four speakers discussed key research findings in syphilis vaccine development, which included antigen selection, identification of epitopes associated with protective immunity, and delivery platforms, with great emphasis on development of chimeric antigens. Significant progress was also shown on the elucidation of Treponema pallidum genomes from virtually all continents to assess the diversity in vaccine candidates of the syphilis spirochete.
- 22 July 2024
- Published by Wolters Kluwer Health in Sexually Transmitted Diseases
- Vol. 51 (11) , e49-e53
Open AccessNew Pathways in Syphilis Vaccine Development
The New Pathways in Syphilis Vaccine Development meeting was held before the start of the STI & HIV 2023 World Congress as a pre-meeting symposium to highlight recent advances in the development of an effective syphilis vaccine and discuss the challenges still faced by investigators. Internationally renowned public health officials, clinical investigators, and basic researchers from academia, government, and community-based organizations met on July 24, 2023, in Chicago, Illinois. Four speakers discussed key research findings in syphilis vaccine development, which included antigen selection, identification of epitopes associated with protective immunity, and delivery platforms, with great emphasis on development of chimeric antigens. Significant progress was also shown on the elucidation of Treponema pallidum genomes from virtually all continents to assess the diversity in vaccine candidates of the syphilis spirochete.
- Open Access
- 11 June 2024
- Published by Wolters Kluwer Health in Sexually Transmitted Diseases
- Vol. 51 (11) , e46-e48
Trends in Sexually Transmitted Infections Associated With the Doxycycline Postexposure Prophylaxis Guidelines in San Francisco
The San Francisco Department of Public Health was the first to issue guidance on the use of doxycycline for postexposure prophylaxis against sexually transmitted infections in at-risk populations. We investigated the association between the issuance of these guidelines and rates of male rectal chlamydia, male rectal gonorrhea, and adult male syphilis.
- 11 June 2024
- Published by Wolters Kluwer Health in Sexually Transmitted Diseases
- Vol. 51 (11) , e46-e48
Open AccessTrends in Sexually Transmitted Infections Associated With the Doxycycline Postexposure Prophylaxis Guidelines in San Francisco
The San Francisco Department of Public Health was the first to issue guidance on the use of doxycycline for postexposure prophylaxis against sexually transmitted infections in at-risk populations. We investigated the association between the issuance of these guidelines and rates of male rectal chlamydia, male rectal gonorrhea, and adult male syphilis.
- Open Access
- 12 July 2023
- Published by Taylor & Francis in CNS Oncology
- Vol. 12 (3) , CNS100
Long-term survival after salvage pemetrexed for refractory primary T-cell lymphoma of the CNS
Primary T-cell CNS lymphoma is a rare and aggressive malignancy. High-dose methotrexate (MTX) based chemotherapy regimens are used as standard first-line treatment, followed by consolidative strate...
- 12 July 2023
- Published by Taylor & Francis in CNS Oncology
- Vol. 12 (3) , CNS100
Open AccessLong-term survival after salvage pemetrexed for refractory primary T-cell lymphoma of the CNS
Primary T-cell CNS lymphoma is a rare and aggressive malignancy. High-dose methotrexate (MTX) based chemotherapy regimens are used as standard first-line treatment, followed by consolidative strate...